(Q39159172)

English

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.

scientific article published on 29 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Martin McLaughlin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

J N Kyula

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

D Mansfield

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E M Karapanagiotou

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

V Roulstone

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Zaidi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

T Pencavel

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Y Touchefeu

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R Seth

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

N G Chen

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Y A Yu

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Q Zhang

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A A Melcher

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R G Vile

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

H S Pandha

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M Ajaz

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A A Szalay

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

K J Harrington

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

0 references

publication date

29 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

full work available at URL

http://eprints.whiterose.ac.uk/87581/

content deliverer

White Rose Research Online

object has role

0 references

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1700-1712

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1038/onc.2013.112

0 references

Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

MAPK pathways in radiation responses

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Permissivity of the NCI-60 cancer cell lines to oncolytic Vaccinia Virus GLV-1h68

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Oncolytic vaccinia therapy of squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

The evolving role of radiation therapy in the management of malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Oncolytic Vaccinia virus and radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non-small-cell lung, pancreatic, colon, and breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Melanoma biology and new targeted therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Management of metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain Metastases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Efficacy of oncolytic herpesvirus NV1020 can be enhanced by combination with chemotherapeutics in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Activation of the PI3K/Akt Pathway Early during Vaccinia and Cowpox Virus Infections Is Required for both Host Survival and Viral Replication

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Signaling to gene activation and cell death by tumor necrosis factor receptors and Fas.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

21 January 2018

Melanoma genetics and the development of rational therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.112

31 March 2020

Identifiers

10.1038/ONC.2013.112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

10.1038/ONC.2013.112

0 references

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23624923%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39159172&oldid=2171425765"